Real-world effectiveness of goserelin 10.8-mg compared to goserelin 3.6-mg in premenopausal and perimenopausal Chinese patients with hormone receptor positive breast cancer: a cohort study
Real-world effectiveness of goserelin 10.8-mg compared to goserelin 3.6-mg in premenopausal and perimenopausal Chinese patients with hormone receptor positive breast cancer: a cohort study
Jinming Yu, Huaqing Yang, Sujie Ni, Hao Wang et al.
Journal
Journal of the National Cancer Center
Topics
HER2/EGFR in Cancer Research
article
Real-world effectiveness of goserelin 10.8-mg compared to goserelin 3.6-mg in premenopausal and perimenopausal Chinese patients with hormone receptor positive breast cancer: a cohort study
Sun Yat-sen University (CN), Nantong University (CN), Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Sichuan University (CN), Tianjin Medical University Cancer Institute and Hospital (CN), Soochow University (CN), Affiliated Hospital of Nantong University (CN), Qinghai University Affiliated Hospital (CN), West China Hospital of Sichuan University (CN), Fudan University Shanghai Cancer Center (CN), Shandong Tumor Hospital (CN), Shanxi Provincial Cancer Hospital (CN), Hunan Cancer Hospital (CN), Sichuan Cancer Hospital (CN), Panyu District Central Hospital (CN), Second Affiliated Hospital of Soochow University (CN), Taiyuan Central Hospital (CN), Sun Yat-sen University Cancer Center (CN), First Affiliated Hospital of Soochow University (CN), Second Affiliated Hospital of Zhejiang University (CN), Shandong First Medical University (CN)